コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eisseria meningitidis, Escherichia coli, and Pseudomonas aeruginosa infection).
2 (KO) mice with aerosolized LPS (100 mug) or Pseudomonas aeruginosa infection.
3 se is critical in the prognosis of pulmonary Pseudomonas aeruginosa infection.
4 eased in splenic natural killer cells during Pseudomonas aeruginosa infection.
5 f CF BAL fluid samples from patients without Pseudomonas aeruginosa infection.
6 ssociated with refractory CRS and persistent Pseudomonas aeruginosa infection.
7 ppaB signalling upon Gram-negative bacterium Pseudomonas aeruginosa infection.
8 cterial clearance and survival of mice after Pseudomonas aeruginosa infection.
9 's tautomerase activity in a murine model of Pseudomonas aeruginosa infection.
10 the eye from pathogenic Candida albicans or Pseudomonas aeruginosa infection.
11 ctors associated with both chronic and acute Pseudomonas aeruginosa infection.
12 t poly(I:C), improved the host response to a Pseudomonas aeruginosa infection.
13 xia succumbed to death during recovery after Pseudomonas aeruginosa infection.
14 rneal perforation in C57BL/6 (B6) mice after Pseudomonas aeruginosa infection.
15 interactions in response to acute pulmonary Pseudomonas aeruginosa infection.
16 tients with cystic fibrosis who have chronic Pseudomonas aeruginosa infection.
17 tibility of cystic fibrosis (CF) patients to Pseudomonas aeruginosa infection.
18 ramycin in patients with cystic fibrosis and Pseudomonas aeruginosa infection.
19 rse outcomes, particularly in the setting of Pseudomonas aeruginosa infection.
20 adult Swiss (HSD:ICR) mice is restored after Pseudomonas aeruginosa infection.
21 ronounced hypersusceptibility (80 to 90%) to Pseudomonas aeruginosa infection.
22 sponse of cystic fibrosis and sensitivity to Pseudomonas aeruginosa infections.
23 e challenged two strains of mice with lethal Pseudomonas aeruginosa infection 3 weeks after immunizat
24 ted (68 vs. 77%, p < 0.001), higher rates of Pseudomonas aeruginosa infection (71 vs. 65%, p < 0.01),
26 choice in the setting of multidrug-resistant Pseudomonas aeruginosa infections, although high doses o
27 fection among HIV-negative patients and with Pseudomonas aeruginosa infections among HIV-positive pat
28 nitial point of host-pathogen interaction in Pseudomonas aeruginosa infection, an important pathogen
29 e the in vivo functions of SPLUNC1 following Pseudomonas aeruginosa infection and to elucidate the un
30 of CF lung disease while adjusting for age, Pseudomonas aeruginosa infection, and cystic fibrosis tr
31 urine listeriosis model, the neutropenic rat Pseudomonas aeruginosa infection, and the mouse cecal li
33 rventions to treat multidrug-resistant (MDR) Pseudomonas aeruginosa infections are severely limited a
34 esponse (within 24 hours) to an experimental Pseudomonas aeruginosa infection between vitamin A defic
35 induced in mouse macrophages in response to Pseudomonas aeruginosa infection both in vivo and by iso
36 r cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection, but there has not been
41 y observed in clinical isolates from chronic Pseudomonas aeruginosa infections, enables bacteria to e
42 p=0.037) when adjusted for sex, BMI, chronic Pseudomonas aeruginosa infection, FEV1/FVC (forced vital
46 ns cells were induced into the cornea before Pseudomonas aeruginosa infection in BALB/c mice that are
50 tor mutation to the onset and persistence of Pseudomonas aeruginosa infection in the airways, and her
51 w immunogenic antigens that diagnose initial Pseudomonas aeruginosa infections in patients with cysti
52 promoter exhibited an elevated resistance to Pseudomonas aeruginosa infection, indicating that these
57 A novel immunochemical approach to diagnose Pseudomonas aeruginosa infections is reported, which is
58 ic endobronchiolitis compounded by recurring Pseudomonas aeruginosa infections is the major cause of
61 cornea keratitis model was modified to study Pseudomonas aeruginosa infection of healing corneal epit
62 tactic gradients, and migrate in response to Pseudomonas aeruginosa infection of primary ALI barriers
64 was not altered by genotype, age, gender, or Pseudomonas aeruginosa infection, oral steroid treatment
65 the incidence or severity of Klebsiella and Pseudomonas aeruginosa infections, patients admitted to
66 Splenic natural killer cells activated upon Pseudomonas aeruginosa infection produced interferon-gam
70 n cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection, the underlying mechani
71 nts who were ExBF >/=2 mo, and the number of Pseudomonas aeruginosa infections through the age of 2 y
72 leus, histamine blocker use, and respiratory Pseudomonas aeruginosa infection were associated with lo
73 bacterial outgrowth from cells subjected to Pseudomonas aeruginosa infection were used to determine
74 e synthesis and cell viability in a model of Pseudomonas aeruginosa infection where Ca(2+) concentrat
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。